Beyond Inc Acquires Buy Buy Baby Brand Rights Reunites with Bed Bath Beyond Strait of Hormuz Disruption Could Tighten LNG Markets and Push Oil Prices to 200 Why Russian Oil Flows Are Increasing in Singapore Explainer Union Pacific UP Refutes New Attorney General Claims on Merger Transparency Dow Jones Industrial Average Reaches Record High as Middle East Optimism Boosts Wall Street Iran Deal Might Trigger Stock Market Selloff Contrary to Wall Street Optimism C4 Therapeutics CCCC Q1 2026 Earnings Narrowing Losses Drive Surprise Beat Despite Zero Revenue Contango ORE Inc CTGO Q1 2026 Earnings Significant EPS Miss Weighs on Shares BNED Q4 2025 Earnings Loss Narrows More Than Expected Shares Rise RRC Q1 2026 Earnings EPS Beats Estimates by 19 Amid Operational Efficiency NICE Q1 2026 Earnings EPS Beats Estimates Amid Mixed Market Reaction American Strategic Investment Co Q1 2026 Earnings Widened Loss Amidst Portfolio Realignment DTE Energy Debenture DTK Edges Higher as YieldSeeking Investors Find Support at 2457 Under Armour UAA Rallies 29 as Shares Test Key Resistance Near 600 Black Rock Coffee Bar BRCB Rallies 1427 Analyzing Support Resistance and NearTerm Potential Clearfield Inc CLFD Surges Nearly 5 as Stock Breaks Above Key Support Level Gabelli Global Small and Mid Cap Value Trust GGZ Advances 129 as It Tests Key Resistance Stolen Identities Driving Cyberattack Surge Implications for Financial Security SACH Q1 2026 Earnings Massive EPS Surprise Miss Drives Stock Down 25 Ondas Inc ONDS Surges 105 Breaking Out Towards Key Resistance Lifetime Brands Inc LCUT Q1 2026 Earnings Impressive EPS Surprise Drives Stock Higher UUUU Q1 2026 Earnings NarrowerThanExpected Loss as Uranium Market Remains Subdued DTG Q1 2026 Earnings EPS Miss Raises Caution on Utility Performance Aptiv PLC Q1 2026 Earnings Strong EPS Beat Signals Operational Discipline Amid Demand Uncertainty STRC Q1 2026 Earnings Significant EPS Miss Driven by Large Loss Alexanders Inc ALX Q1 2026 Earnings Solid EPS Performance Amid Limited Disclosures Verrica Pharmaceuticals VRCA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Stage Continues